NCT05556096 2026-04-21
Safety and Efficacy of ALXN1720 in Adults With Generalized Myasthenia Gravis
Alexion Pharmaceuticals, Inc.
Phase 3 Active not recruiting
Clinical Trials
8 trialsNCT05644561 2026-04-17
Evaluation of PK, PD, Efficacy, Safety, and Immunogenicity of IV Ravulizumab in Pediatric Participants With Generalized Myasthenia Gravis
Alexion Pharmaceuticals, Inc.
Phase 3 Active not recruiting
NCT05403541 2026-03-25
Phase 3 Study to Assess the Efficacy and Safety of Batoclimab as Induction and Maintenance Therapy in Adult Participants With Generalized Myasthenia Gravis
Immunovant Sciences GmbH
Phase 3 Active not recruiting
NCT04524273 2026-03-10
MINT
Amgen
Phase 3 Active not recruiting
NCT04225871 2026-02-27
RAISE-XT
UCB Pharma
Phase 3 Active not recruiting
NCT05070858 2026-02-12
NIMBLE
Regeneron Pharmaceuticals
Phase 3 Active not recruiting
NCT06558279 2025-12-15
ADAPT oculus
argenx
Phase 3 Active not recruiting
NCT06298552 2025-11-05
ADAPT SERON
argenx
Phase 3 Active not recruiting